1Hann HW, Evans AE, Siegel SE, et al. Prognostic importance of serum ferritin in patients with stages Ⅲ and IV neuroblastoma:The Children's Cancer Study Group experience [ J ]. Cancer Res, 1985,45 ( 6 ) : 2843 - 2848.
2Shuster J J, McWilliams NB, Castleberry R ,et al. Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study [ J ]. Am J Clin Oncol, 1992,15 ( 4 ) : 295 - 303.
3de Bernardi B, Pianca C, Boni L, et al. Disseminated neuroblastoma (stage IV and IV -S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma [ J ]. Cancer, 1992,70(6) : 1625 - 1633.
4Lastowska M, Cullinane C, Variend S, et al. United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group: Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors [ J ]. J Clin Oncol,2001 , 19 ( 12 ) : 3080 - 3090.
5Shimada H,Ambros IM,Dehner LP,et al. The international neuroblastoma pathology classification (the Shimada system) [ J]. Cancer, 1999, 86(2) :364 -372.
6Goto S, Umehara S, Gerbing RB,et al. Histopathology( international neuroblastoma pathology classification) and MYCN status in patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group [ J ]. Cancer,2001,92 ( 10 ) :2699 - 2708.
7Kubota M, Suita S,Tajiri T,et al. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma[ J ]. J Pediatr Surg,2000,35 ( 1 ) :92 - 95.
8Matthay KK, Castleberry RP. Treatment of advanced neuroblastoma: The US experience [ M ]//Brodeur GM, Sawada T, Tsuchida Y, et al. Neuroblastoma. Amsterdam : Elsevier Science,2000:417 - 436.
9Kushner BH,LaQuaglia MP, Bonilla MA,et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age [ J]. J Clin Oncol, 1994,12( 12 ) :2607 - 2613.
10Nitschke R, Parkhurst J, Sullivan J, et al. Topotecan in pediatric patients with recurrent and progressive solid tumors:A Pediatric Oncology Group phase Ⅱ study[J]. J Pediatr Hematol Oncol, 1998,20(4) :315 - 318.
